Patient Case Study: Stage IV Small Cell Lung Cancer

Convenient Complement to Imaging

Northstar Response®-Informed Treatment Summary

‍

BACKGROUND

RESULTS

‍

TAKEAWAY

Northstar's real-time view of tumor burden change can help optimize the therapy strategy for patients on treatment. The convenience of a blood-only based therapy response monitoring tool can help inform the effectiveness of treatment in advance of standard imaging, potentially offering more time-sensitive signals for treatment planning.

• What poential treatment changes could have been made if you know that tumor burden was increasing 6 months before imaging confirmed progression?
• What potential impact does early insight into treatment response have on a patient's likelihood to adhere to the prescribed treatment?

‍